Background:: Hepcidin is a master regulator of iron metabolism primarily produced by the liver. Markedly increased hepcidin levels have been observed in septic individuals, while decreased hepatic hepcidin expression has been demonstrated in liver diseases that tend to develop into sepsis. However, the role of liver hepcidin in sepsis remains unknown.
Methods:: Mouse hepatic hepcidin expression was silenced using adenovirus-mediated hepcidin-specific short hairpin RNA injected via the tail vein. Sepsis was induced by cecal ligation and puncture, and the outcome (n = 23 for hepcidin knockdown mice, n = 15 for controls) and pathogenic changes (n = 5) related to sepsis were evaluated. The impact of alteration of iron status on the survival rate of hepatic hepcidin knockdown mice (n = 18 to 19) was also investigated.
Results:: Disruption of liver hepcidin expression increased serum iron level (537.8 ± 28.1 μg/dl [mean ± SD] vs. 235.9 ± 62.2 μg/dl; P < 0.05) and reduced iron content in the spleen macrophages at the steady state. Hepatic hepcidin knockdown mice not only showed increased 7-day mortality (73.9% vs. 46.7%; P < 0.05), but also had exacerbated organ damage and oxidative stress, as well as compromised host inflammatory responses and bacterial clearance at 24 h after polymicrobial sepsis. Treating the hepatic hepcidin knockdown mice with low-iron diet plus iron chelation decreased systemic iron content (serum level: 324.0 ± 67.4 μg/dl vs. 517.4 ± 13.4 μg/dl; P < 0.05) and rescued the mice from lethal sepsis (7-day survival: 36.8% vs. 83.3%; P < 0.01).
Conclusions:: Hepatic hepcidin plays an important role in sepsis through regulation of iron metabolism. The findings may have potential therapeutic implications for liver diseases in which hepcidin expression is decreased.
Disruption of mouse hepatic hepcidin expression led to significant increases in organ damage and mortality when sepsis was produced. Decreasing the iron levels in these mice improved survival.
Markedly increased hepcidin levels have been observed in septic patients, while decreased hepatic hepcidin expression has been demonstrated in liver diseases that tend to develop into sepsis.
CongLi Zeng, QiXing Chen, Kai Zhang, QingHua Chen, ShengWen Song, XiangMing Fang; Hepatic Hepcidin Protects against Polymicrobial Sepsis in Mice by Regulating Host Iron Status. Anesthesiology 2015;122(2):374-386. doi: https://doi.org/10.1097/ALN.0000000000000466.
Download citation file:
© 2019 American Society of Anesthesiologists
Welcome!
We have emailed you at with instructions on how to set up a new password. If you do not receive an email in the next 24 hours, or if you misplace your new password, please contact:
ASA members: Contact WK Member Services Memberservice@lww.com US and Canada: 866-489-0443 Worldwide: 301-223-2300
or
Non-member individual subscribers: Contact WK Customer Service Customerservice@lww.com US and Canada: 1-800-638-3030 Worldwide: 301-223-2300
...but there is no email account associated with it. To get started with Anesthesiology, we'll need to send you an email. To add an email address to your ASA account please contact us:
Forgot your password? Enter your username and email address. We'll send you a link to reset your password.
Forgot your username? Enter your email address. We'll send you your username identified by your email account.